Ovarian Cancer - Drug Pipeline Landscape, 2023 | Acepodia Biotech, Inc., Acrivon Therapeutics, Acrotech Biopharma, Actuate Therapeutics, Adaptimmune

New York, Global Insight Services have recently published a report on Ovarian Cancer - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.

Read more about Ovarian Cancer - Drug Pipeline Landscape here: https://www.globalinsightservices.com/reports/ovarian-cancer-drug-pipeline-landscape/

Ovarian Cancer is a growth of abnormal cells in the ovaries or fallopian tubes and peritoneum which can multiply without any control. It is of three types based on the origination in cell types which are epithelial ovarian cancer, stromal tumor and germ cell tumor.

Request for a PDF sample copy of report: https://www.globalinsightservices.com/request-sample/GIS31084

The exact cause of Ovarian cancer is still unclear but the risk factors include family history of ovarian/breast cancer, inherited gene mutations (BRCA1 or BRCA2) or Lynch syndrome, age, obesity, endometriosis, hormone replacement treatment, never been pregnant.

The most common symptoms of Ovarian cancer include vaginal bleeding (post menopause), abnormal vaginal discharge, bloating, pelvic and/or abdominal pain, discomfort, back pain, bowel changes (diarrhea or constipation), frequent urination, fatigue, loss of appetite.

Report Highlights

Global Insight Service's, Ovarian Cancer - Drug Pipeline Landscape, 2023 report provides an overview of the Ovarian Cancer pipeline drugs. This report covers detailed insights on Ovarian Cancer drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Ovarian Cancer pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Scope

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clincial trials, and key upcoming milestones are included.

Some of the key players involved in development of Ovarian Cancer therapeutics are :

• 4D pharma plc
• A STAR Research Entities
• A2 Biotherapeutics
• AbbVie
• Abclon
• Acepodia Biotech, Inc.
• Acrivon Therapeutics
• Acrotech Biopharma
• Actuate Therapeutics
• Adaptimmune
• ADC Therapeutics S.A.
• Advenchen Laboratories, LLC
• Agenus Inc.
• AIM ImmunoTech Inc
• Aivita Biomedical, Inc.

Buy this report: https://www.globalinsightservices.com/checkout/single_user/GIS31084

With Global Insight Services, you receive:

-10-year forecast to help you make strategic decisions
-In-depth segmentation which can be customized as per your requirements
-Free consultation with lead analyst of the report
-Excel data pack included with all report purchases
-Robust and transparent research methodology

Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior

This release was published on openPR.